Ginkgo Bioworks to discover and develop novel vaccine adjuvants
Drug Discovery World
FEBRUARY 20, 2024
A five-year contract totalling up to $31 million including programme options has been awarded to Ginkgo Bioworks to discover and develop next-generation vaccine adjuvants. The partners also intend to develop more affordable, sustainable, and scalable adjuvant manufacturing processes.
Let's personalize your content